Healthcare Trust of America, In (NYSE:HTA).
On June 20 the company was changed to a “Outperform” in a report from BMO Capital which was a boost from the previous “Market Perform” rating. On November 7 the company was upgraded from “” to “Outperform” in a report from Raymond James.
On August 25 analysts at BTIG Research initiated coverage on HTA by announcing an initial rating of “Buy” and projecting a price target of $37.00. Equity analyst SunTrust Robinson Humphrey issued its first research report on the stock with an initial rating of “Buy”.
Oppenheimer initiated coverage setting a rating of “Outperform” and establishing a price target of $31.00.
The company is trading up since yesterday’s close of $29.51. Additionally Healthcare Trust of America, In recently declared a dividend paid on Tuesday July 11th, 2017. The dividend payment was $0.300 per share for the quarter or $1.20 annualized. This dividend amount was represent a yeild of $3.98. The ex-dividend date was Thursday the 6th of April 2017.
It is currently trading at $29.66 slightly below the 50 day moving average which is $31.54 and a bit lower than the 200 day moving average of $30.70. The 50 day moving average went down $-1.81 or -5.74% whereas the 200 day average was down by -3.16%.
Healthcare Trust of America, Inc., launched on April 20, 2006, is a real estate investment trust. The Company is an owner and operator of medical office buildings (MOBs) in the United States. The Company focuses on owning and operating MOBs that serve healthcare delivery and are located on health system campuses, near university medical centers, or in community core outpatient locations. As of December 31, 2016, the Business’s portfolio consisted of approximately 17.7 million square feet of gross leasable area. As of December 31, 2016, the Business’s portfolio included MOBs, such as single-tenant and multi-tenant, and other healthcare facilities, such as hospitals and senior care. As of December 31, 2016, the Business’s portfolio had 355 buildings located in 31 states..
The P/E ratio is 87.44 and the market cap is 4.28B. In the last earnings report the EPS was $0.34 and is expected to be $0.30 for the current year with 143,841,000 shares now outstanding. Next quarter’s EPS is expected be $0.03 with next year’s EPS projected to be $0.15.